NEUROPHET, Inc. (KOSDAQ:380550)
South Korea
· Delayed Price · Currency is KRW
20,700
-300 (-1.43%)
Apr 29, 2026, 3:30 PM KST
NEUROPHET Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
| Net Income | -22,389 | -15,101 |
| Depreciation & Amortization | 1,110 | 1,095 |
| Loss (Gain) From Sale of Assets | 0.08 | 3.48 |
| Stock-Based Compensation | 591.83 | 552.27 |
| Provision & Write-off of Bad Debts | 347.3 | 0.13 |
| Other Operating Activities | 5,962 | 942.32 |
| Change in Accounts Receivable | -172.55 | -144.57 |
| Change in Inventory | -20.59 | 13.08 |
| Change in Other Net Operating Assets | -496.55 | 26.95 |
| Operating Cash Flow | -15,067 | -12,613 |
| Capital Expenditures | -265.46 | -248.74 |
| Sale of Property, Plant & Equipment | 0.51 | 6.86 |
| Sale (Purchase) of Intangibles | -59.47 | -143.25 |
| Investment in Securities | -16,100 | 9,000 |
| Other Investing Activities | 66.93 | 3 |
| Investing Cash Flow | -16,357 | 8,618 |
| Long-Term Debt Issued | 5,000 | - |
| Long-Term Debt Repaid | -625.6 | -655.84 |
| Net Debt Issued (Repaid) | 4,374 | -655.84 |
| Issuance of Common Stock | 28,141 | - |
| Financing Cash Flow | 32,516 | 342.21 |
| Foreign Exchange Rate Adjustments | -7.23 | 0.92 |
| Net Cash Flow | 1,084 | -3,652 |
| Free Cash Flow | -15,332 | -12,862 |
| Free Cash Flow Margin | -586.30% | -580.35% |
| Free Cash Flow Per Share | -1576.43 | -3484.24 |
| Cash Interest Paid | 48.52 | 0 |
| Cash Income Tax Paid | -52.13 | 49.81 |
| Levered Free Cash Flow | -39,964 | - |
| Unlevered Free Cash Flow | -39,389 | - |
| Change in Working Capital | -689.69 | -104.55 |
Source: S&P Capital IQ. Standard template.
Financial Sources.